EUVIMEDEUVIMED entdecken
Fallbericht

Combined Immunoglobulin Heavy‐ and Light‐Chain Amyloidosis Associated With Waldenström Macroglobulinaemia: A Case Report With Diagnostic Challenges and a Favourable Treatment Outcome

Ryo Yamaguchi, Yusuke Murata, Shunsuke Kawamoto, Yurie Akiya, Seiichiro Hemmi, Katsuhiro Miura iD, Masanori Abe

Nephrology · 2026-06 · 31 (6)

DOI: 10.1111/nep.70235 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Nephrology, online erschienen am 09.06.2026. Verfasst von Ryo Yamaguchi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Hypertension and Endocrinology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: Waldenstrom Macroglobulinemia, Immunoglobulin Light-chain Amyloidosis, Antineoplastic Combined Chemotherapy Protocols, Amyloidosis. Die Arbeit nennt 18 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Waldenström macroglobulinaemia (WM) is a rare lymphoplasmacytic lymphoma that produces monoclonal IgM, and renal amyloidosis is an uncommon complication. Light‐chain amyloidosis occurs more frequently than heavy‐chain or combined heavy‐ and light‐chain (AHL) amyloidosis. This report describes a woman with proteinuria in the nephrotic range, elevated IgM, and IgM kappa monoclonal protein in serum and urine. Kidney biopsy revealed AHL amyloidosis with IgM and kappa deposition. Laser microdissection–liquid chromatography–tandem mass spectrometry (LMD‐LC–MS/MS) confirmed the presence of peptides from heavy and light chains. WM with renal amyloidosis was diagnosed, and the patient was started on bendamustine and rituximab. She had a significant hematologic response, achieving a very good partial response according to the international criteria. A renal response characterized by a reduction in proteinuria and stabilization of renal function was also observed. The patient remains asymptomatic after 43 months of follow‐up. This case of WM with renal AHL amyloidosis highlights the importance of keeping renal amyloidosis in mind in patients with proteinuria. The favourable hematologic and renal response to treatment with bendamustine and rituximab in this case adds valuable data for the management of WM complicated by renal amyloidosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Waldenstrom MacroglobulinemiaImmunoglobulin Light-chain AmyloidosisAntineoplastic Combined Chemotherapy ProtocolsAmyloidosisHumansFemaleBendamustine HydrochlorideTreatment OutcomeRituximabBiopsyTandem Mass SpectrometryKidney

Stichwörter der Autor:innen

Waldenström macroglobulinaemialaser microdissectionliquid chromatographyrenal amyloidosistandem mass spectrometry (LMD‐LC–MS/MS)

Substanzen

Bendamustine HydrochlorideRituximab

Autor:innen und Institutionen

  • Division of Nephrology, Hypertension and Endocrinology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan.
  • Division of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan.

ORCID-Profile: Katsuhiro Miura

Zitieren

APA

Yamaguchi, R., Murata, Y., Kawamoto, S., Akiya, Y., Hemmi, S., Miura, K., & Abe, M. (2026). Combined Immunoglobulin Heavy‐ and Light‐Chain Amyloidosis Associated With Waldenström Macroglobulinaemia: A Case Report With Diagnostic Challenges and a Favourable Treatment Outcome. Nephrology, 31(6). https://doi.org/10.1111/nep.70235

Vancouver

Yamaguchi R, Murata Y, Kawamoto S, Akiya Y, Hemmi S, Miura K, et al. Combined Immunoglobulin Heavy‐ and Light‐Chain Amyloidosis Associated With Waldenström Macroglobulinaemia: A Case Report With Diagnostic Challenges and a Favourable Treatment Outcome. Nephrology. 2026;31(6). doi:10.1111/nep.70235

BibTeX
@article{Yamaguchi2026,
  author = {Yamaguchi, Ryo and Murata, Yusuke and Kawamoto, Shunsuke and Akiya, Yurie and Hemmi, Seiichiro and Miura, Katsuhiro and Abe, Masanori},
  title = {Combined Immunoglobulin Heavy‐ and Light‐Chain Amyloidosis Associated With Waldenström Macroglobulinaemia: A Case Report With Diagnostic Challenges and a Favourable Treatment Outcome},
  journal = {Nephrology},
  year = {2026},
  volume = {31},
  number = {6},
  doi = {10.1111/nep.70235}
}
Kostenlos starten →